Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05326750). This is a study registration, not published results. Lead sponsor: Kuopio University Hospital. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 200 participants (ESTIMATED). Conditions: Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies. Interventions: DEVICE: Gamma tACS (40 Hz) over the superior parietal cortex. Primary outcome measures: Changes in Rey Auditory Verbal Learning Test score , Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention; Changes in Rey Auditory Verbal Learning Test, recognition , Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention; Changes in orientation to time and place (MMSE questions 1-10) , Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention; Changes in Trail Making A & B tests , Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention; Changes in INECO Frontal Screening test , Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention; Changes in phonemic fluency , Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention. Brief summary: Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.